Keros Historical Valuation

KROS Stock  USD 11.08  0.07  0.64%   
Some fundamental drivers such as market cap or Keros Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Keros Therapeutics valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Keros Therapeutics's future value.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Keros Stock please use our How to Invest in Keros Therapeutics guide.

About Keros Valuation Data Analysis

Valuation is the financial process of determining what Keros Therapeutics is worth. Keros Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Keros Therapeutics valuation ratios help investors to determine whether Keros Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Keros with respect to the benefits of owning Keros Therapeutics security.

Keros Therapeutics Valuation Data Chart

Market Cap is likely to gain to about 661.9 M in 2025, whereas Enterprise Value is likely to drop slightly above 49 M in 2025.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Keros Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Keros Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Keros Therapeutics value than its market capitalization because it takes into account all of Keros Therapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Keros Stock Analysis

When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.